Extract Or Material Containing Or Obtained From A Multicellular Fungus As Active Ingredient (e.g., Mushroom, Filamentous Fungus, Fungal Spore, Hyphae, Mycelium, Etc.) Patents (Class 424/195.15)
-
Patent number: 7749508Abstract: The present invention provides an antioxidant and a whitening agent having high safety, and a external preparation for skin using the same. The antioxidant and whitening agent comprise, as an effective component, one or more extracts from Basidiomycetes selected from the group consisting of Pleurotus abalonus, Pholiota squarrosa, Onnia orientalis, Astraeus hygrometricus and Pleurotus nebrodensis . These extracts have a free radical capturing ability and are useful for suppressing skin oxidation and for preventing and improving skin aging. In addition, the extracts have a tyrosinase activity inhibiting action and can suppress the melanin generation. Since the fruit bodies of these Basidiomycetes have been used for edible purpose and have high safety, they can be used preferably for an external preparation for skin.Type: GrantFiled: February 5, 2009Date of Patent: July 6, 2010Assignees: Shiseido Co., Ltd., Fumio EguchiInventors: Takeshi Nawamura, Nobuhiko Ochiai, Masato Hatao, Mineyuki Yokoyama, Koji Kobayashi, Fumio Eguchi
-
Publication number: 20100166796Abstract: This invention provides a method of improving glutathione (GSH) concentrations, both intra and extra-cellularly, in animals, thereby improving the cellular function of the immune and other bodily organ functions. The invention is directed toward a composition treating glutathione deficient animals which comprises N-acetylcysteine; vitamin C; L-glutamine; Silymarin; Cordyceps sp.; alpha-lipoic acid; and a pharmaceutically acceptable systemic carrier. The composition of the invention optionally comprises one or more of the following quercitin; N-acetyl-D-glucosamine; and dietary protein.Type: ApplicationFiled: January 31, 2008Publication date: July 1, 2010Inventors: Robert Keller, Stacy L. O'Connor
-
Publication number: 20100150955Abstract: A method of producing an extract derived from Lyophyllum ulmarium from fruiting body or mycelium of Lyophyllum ulmarium, wherein the method of producing an extract derived from Lyophyllum ulmarium uses an aqueous alkaline solvent as an extraction solvent; an extract derived from Lyophyllum ulmarium, obtainable by the method as defined above; and a food and a medicament each containing the extract.Type: ApplicationFiled: August 2, 2006Publication date: June 17, 2010Inventors: Hiroshi Endo, Hitoshi Sakakibara, Yasushi Hattori, Kumi Sasaki, Ikunoshin Kato
-
Publication number: 20100143398Abstract: Phytoceutical compositions for the prevention and treatment of circulatory disorders, feminine endocrine disorders, and dermal disorders. A specific combination of extracts of plants is taught, as well as principles for varying the formulations based on categorizing plants into one of three groups, Energy, Bio-Intelligence, and Organization and selecting several plants from each group. Such combinations have synergistic effects, with minimal side effects.Type: ApplicationFiled: February 12, 2010Publication date: June 10, 2010Inventor: José Angel Olalde Rangel
-
Publication number: 20100143397Abstract: Phytoceutical compositions for the prevention and treatment of circulatory disorders, feminine endocrine disorders, and dermal disorders. A specific combination of extracts of plants is taught, as well as principles for varying the formulations based on categorizing plants into one of three groups, Energy, Bio-Intelligence, and Organization and selecting several plants from each group. Such combinations have synergistic effects, with minimal side effects.Type: ApplicationFiled: February 12, 2010Publication date: June 10, 2010Inventor: Jose Angel Olalde Rangel
-
Patent number: 7731984Abstract: The present invention describes substantially pure cultures of three new species of fungi, Meira geulakonigae (CBS 110052), Meira argovae (CBS 110053) and Acaromyces ingoldii (CBS 110050) (all nom. prov.), wherein said cultures are biologically pure. The conditioned medium for all three new fungi species is also described, as well as their biologically active products. The biological product of the three new fungi species and their conditioned medium has miticidal and fungicidal activities. Thus, a composition for the control of mites and/or phytopathogenic fungi comprising a biocontrol agent derived from any one of the three new fungi species is also described, optionally comprising an agriculturally compatible carrier. Finally, the present invention describes a method for producing a fungicide and/or a miticide, wherein the active ingredient of said fungicide/miticide is any one of M. geulakonigae, M. argovae, or A.Type: GrantFiled: January 23, 2003Date of Patent: June 8, 2010Assignee: Yissum Research Development Company of The Hebrew University of JerusalemInventors: Abraham Sztejnberg, Uri Gerson, Aviva Gafni
-
Publication number: 20100119541Abstract: Use of a vegetable drug composition in the manufacturing of a pharmaceutical preparation for the treatment of portal hypertension caused by hepatocirrhosis, said preparation comprises 25-38% of extract of radix Salviae Miltiorrhizae, 20-25% of extract of herb Gynostemmae Pentaphylli, 1-6% of alcoholic extract of fructus Schisandrae Chinensis, 19-26% of extract of Cordyceps, 6-8% of extract of pollen Pini, 6-10% of extract of semen Persicae. Said preparation can improve hepatic cell degeneration, necrosis, intraheptic hemorrhage, fibre proliferation, and reduce pressure of portal vein in mammal. A preparation method of said preparation is disclosed.Type: ApplicationFiled: April 28, 2008Publication date: May 13, 2010Inventors: Lieming Xu, Cheng Liu
-
Publication number: 20100119613Abstract: The present invention relates to a method for producing an extract which is capable of inducing an antioxidant stress response comprising the step of treating an extract from organic material with UV light, said extract being derived from a non-mammalian cell or a non-mammalian organism and said cell or organism being capable of synthesizing polyunsaturated fatty acids. Furthermore, an extract capable of inducing an antioxidant stress response produced in accordance with the inventive methods, in particular an extract capable of inducing an antioxidant stress response for the preparation of a cosmetic composition is disclosed. The present invention also relates to a cosmetic composition comprising the inventive extract obtainable by the method provided herein.Type: ApplicationFiled: April 2, 2008Publication date: May 13, 2010Inventors: Florian Gruber, Olga Oskolkova, Erwin Tschachler, Valery Bochkov
-
Patent number: 7713557Abstract: A natural oriental medicinal composition for the promotion of hair growth is provided. The oriental medicinal composition includes a black bean extract, a tangerine extract, a potato extract, a pine needle extract and a quartzite powder. Since the oriental medicinal composition includes crude drugs extracted from natural substances that can prevent hair loss, it is effective for hair growth and has ensured biostability. Particularly, the oriental medicinal composition allows newborn hair to grow in the form of stiff hair.Type: GrantFiled: July 1, 2009Date of Patent: May 11, 2010Inventor: Hyeong Geun Choi
-
Publication number: 20100104605Abstract: The present invention provides a method for making pressure-induced ganoderma spores, for using the pressure-induced ganoderma spores to ameliorate and/or prevent influenza in a mammal; and to stimulating the host immune system in a mammal. The method for making the pressure-induced ganoderma spores includes (1) soaking ganoderma spores in a solution; (2) drying the soaked ganoderma spores using a freeze-drying or a vacuum-drying method; (3) breaking the sporoderms of the dried ganoderma spores with enzyme or a mechanical method; (4) pressurizing and depressurizing the sporoderm-broken ganoderma spores to obtain the pressure-induced sporoderm-broken ganoderma spores. The methods for ameliorating and/or preventing influenza, and for stimulating the host immune system include orally administering a composition comprising the pressure-induced ganoderma spores to a mammal susceptible to or suffering from influenza. The present invention also provides the pressure-induced ganoderma spores.Type: ApplicationFiled: October 20, 2009Publication date: April 29, 2010Inventors: Chee-Keung Chung, Li Zuo
-
Publication number: 20100098752Abstract: Compositions and methods for administering one or more antioxidants to a human subject have been developed. The antioxidant-containing lipid vesicles of the invention provide a delivery system for antioxidants which can be applied topically to the skin.Type: ApplicationFiled: January 18, 2008Publication date: April 22, 2010Inventor: Mark A. Pinsky
-
Patent number: 7700110Abstract: Disclosed is a composition comprising a combination of: Polygonum fagopyrum seed extract, Chlorella vulgaris extract, palmitoyl wheat protein hydrolysate, algae extract, and tripeptide. The composition may further comprise one or more of the following: Citrus unshiu peel extract, Sphacelaria scoparia extract, Bambusa vulgaris extract, Pisum sativum (pea) extract, Evodia rutaecarpa fruit extract, and dipalmitoylhydroxy proline. Such compositions are useful in methods for aiding in improving skin firmness, lifting the skin, preventing or decreasing skin sagging, and preventing or decreasing visible signs of aging resulting from internal and external causes such as environmental stresses.Type: GrantFiled: May 22, 2007Date of Patent: April 20, 2010Assignee: Access Business Group International LLCInventors: Amy C. Zimmerman, Deborah A. O'Toole
-
Patent number: 7691387Abstract: This invention provides a method for identifying a composition of Cinnamomi and Poria. This invention further provides a composition comprising: Ramulus Cinnamomi, Poria Cortex, Moutan Radicis, Radix Paeonize Alba, and Semen Persicae. This invention provides various uses of these compositions.Type: GrantFiled: March 24, 2006Date of Patent: April 6, 2010Assignee: Jiangsu Kanion Pharmaceutical Co., LtdInventor: Wei Xiao
-
Publication number: 20100080821Abstract: Described herein are caffeine-free compositions that provide a sense of energy and well-being. In one aspect, the compositions include a blend of natural herbs or herbal extracts such as at least one Schizandra, at least one Rhodiola, an eleutheroside, at least one Cordyceps, at least one Lycium (genus of goji), and at least one Ribes to revitalize one's state of well being. Additional herbs, herbal extracts, sweeteners, vitamins, minerals, and additional nutrients may be added to the composition for additional benefits and improved taste. In some embodiments, the composition is provided as a beverage, e.g. a carbonated beverage.Type: ApplicationFiled: September 30, 2009Publication date: April 1, 2010Applicant: SYLMARK, INC.Inventor: Peter Spiegel
-
Publication number: 20100080822Abstract: This invention provides a method for identifying a composition of Cinnamomi and Poria. This invention further provides a composition comprising: Ramulus Cinnamomi, Poria Cortex, Moutan Radicis, Radix Paeonize Alba, and Semen Persicae. This invention provides various uses of these compositions.Type: ApplicationFiled: October 19, 2009Publication date: April 1, 2010Applicant: JIANGSU KANION PHARMACEUTICAL CO., LTD.Inventor: Wei XIAO
-
Patent number: 7687064Abstract: The present disclosure provides methods for increasing the lipopolysaccharide-induced secretion of IL-1 by macrophages, for increasing serum levels of IL-1 in a mammal, for increasing the serum level of IL-1 receptor antagonist (IL-1Ra) in a mammal, for increasing the secretion of IL-1 by a monocyte, for increasing the secretion of IL-1Ra by a monocyte, for increasing the secretion of IL-1Ra by a macrophage, for increasing expression of TLR4 on the surface of a macrophage, for increasing expression of CD14 on the surface of macrophage, for increasing the uptake and clearance of lipopolysaccharide (LPS) by a LPS-stimulated macrophage, and for increasing lipopolysaccharide (LPS)-stimulated activation of at least one of ERK, JNK, and p38 in a macrophage. The methods of the disclosure involve the administration to mammals and immune cells of a fucose-containing glycoprotein fraction from Ganoderma lucidum.Type: GrantFiled: September 21, 2006Date of Patent: March 30, 2010Assignee: Academia SinicaInventors: Kuo-Feng Hua, Hsien-Yeh Hsu, Chi-Huey Wong
-
Patent number: 7682616Abstract: Phytoceutical compositions for the prevention and treatment of circulatory disorders, feminine endocrine disorders, and dermal disorders. A specific combination of extracts of plants is taught, as well as principles for varying the formulations based on categorizing plants into one of three groups, Energy, Bio-Intelligence, and Organization and selecting several plants from each group. Such combinations have synergistic effects, with minimal side effects.Type: GrantFiled: February 17, 2009Date of Patent: March 23, 2010Inventor: Jose Angel Olalde Rangel
-
Patent number: 7682617Abstract: Phytoceutical compositions for the prevention and treatment of circulatory disorders, feminine endocrine disorders, and dermal disorders. A specific combination of extracts of plants is taught, as well as principles for varying the formulations based on categorizing plants into one of three groups, Energy, Bio-Intelligence, and Organization and selecting several plants from each group. Such combinations have synergistic effects, with minimal side effects.Type: GrantFiled: February 17, 2009Date of Patent: March 23, 2010Inventor: Jose Angel Olalde Rangel
-
Patent number: 7682615Abstract: The present invention relates to compositions comprising polypeptides and polysaccharides. The compositions are in general immune modulating. The invention also discloses methods of producing these compositions using filamentous fungi cultivated in liquid medium. The compositions are useful for example in the treatment of immune compromised conditions.Type: GrantFiled: January 25, 2007Date of Patent: March 23, 2010Assignee: BeKa Holding ASInventor: Bjørn Kristiansen
-
Publication number: 20100055201Abstract: The present invention includes methods and compositions for the treatment and prevention of protozoal parasitic infections utilizing Diindolylmethane-related indoles. Additive and synergistic interaction of Diindolylmethane-related indoles with other known anti-parasitic and pro-apoptotic agents is believed to permit more effective therapy and prevention of protozoal parasitic infections. The methods and compositions described provide new treatment of protozoal parasitic diseases of mammals and birds including malaria, leishmaniasis, trypanosomiasis, trichomoniasis, neosporosis and coccidiosis.Type: ApplicationFiled: October 26, 2007Publication date: March 4, 2010Inventor: Michael A. Zeligs
-
Publication number: 20100047269Abstract: The present invention provides a new strain of turkey tail mushroom (Trametes versicolor (L.: Fr.) Pilat) having excellent biological activities (Accession number: FERM BP-10633). The strain is excellent in platelet aggregation inhibitory effect, chemokine gene expression inhibitory effect, antimutagenic effect, antitumor effect, antihypertensive effect, and immunomodulatory effect. The effect of the strain is enhanced synergistically by combining with microalgae and other basidiomycetes. The turkey tail mushroom of the present invention has high safety, and a possibility that a side effect is caused because of long-term continuous use is very low. Thus, it is useful for food/drink, cosmetics, pharmaceuticals or the like, the objective of which is the prevention and improvement in inflammation, allergy, tumor, and other diseases.Type: ApplicationFiled: July 28, 2006Publication date: February 25, 2010Applicant: NIKKEN SOHONSHA CORPORATIONInventors: Fumio Eguchi, Ryo Sumi, Nobuo Mori
-
Publication number: 20100047221Abstract: The present invention provides a composition comprising pyruvic acid alkyl ester for ingestion by a human as a food, oral supplement or pharmaceutical.Type: ApplicationFiled: April 4, 2007Publication date: February 25, 2010Inventor: Ranya L. Alexander
-
Patent number: 7666913Abstract: The object of the present invention is to provide a drug effective in treating or preventing osteoporosis. The present invention discloses a therapeutic or preventive drug for osteoporosis having a compound shown in the formula (1) (wherein R1 is an alkyloxy group with the carbon number of 1 to 4) or a pharmaceutically acceptable salt or ester of said compound in the formula (1) as an effective ingredient. In the compound of the formula (1), a substance in which R1 is CH3O is isotaxiresinol derived from Taxus yunanennsis and showed physiological activities in inhibiting bone resorption and improving bone formation.Type: GrantFiled: January 27, 2005Date of Patent: February 23, 2010Assignee: Kotosugi Inc.Inventors: Shigetoshi Kadota, Takahiro Nobukawa
-
Patent number: 7662598Abstract: The present invention provides a method for extracting lipids from microorganisms without using organic solvent as an extraction solvent. In particular, the present invention provides a method for extracting lipids from microorganisms by lysing cells and removing water soluble compound and/or materials by washing the lysed cell mixtures with aqueous washing solutions until a substantially non-emulsified lipid is obtained.Type: GrantFiled: July 24, 2007Date of Patent: February 16, 2010Assignee: Martek Biosciences CorporationInventors: Craig M. Ruecker, Swithwin Patrick Adu-peasah, Brian S. Engelhardt, George T. Veeder, III
-
Patent number: 7658956Abstract: A Phytoceutical composition for the prevention and treatment of erectile dysfunction is provided. A specific combination of extracts of plants and nutraceuticals is based on categorizing plants and nutraceuticals into one of three groups, Energy, Bio-Intelligence, and Organization. Such combination has synergistic effects, with minimal side effects.Type: GrantFiled: July 28, 2006Date of Patent: February 9, 2010Inventor: Jose Angel Olalde Rangel
-
Publication number: 20100028318Abstract: The present invention has its object to provide a safer and highly effective composition capable of relieving or preventing xerostomia. The present invention relates to an agent for relieving or preventing xerostomia comprising an oxidized coenzyme Q and/or a reduced coenzyme Q as active ingredients, a composition containing the agent for relieving or preventing xerostomia in a form of a food product, a health food, a dietary supplement, a supplement, an oral health care product, a medicament, a quasi drug, a pet food, a feed or the like, and a method for treating xerostomia and a method for reducing risks of xerostomia comprising administering the composition.Type: ApplicationFiled: January 31, 2008Publication date: February 4, 2010Applicants: KANEKA CORPORATIONInventors: Ichiro Saito, Kenji Fujii, Kazuya Hamada
-
Publication number: 20100021426Abstract: The present invention relates to novel and non-obvious methods and media for preparing fermentation products of Cordyceps sinensis. The present invention also relates to novel and non-obvious compositions comprising fermentation products of Cordyceps sinensis produced by the methods of the invention or obtained from other sources. The present invention also relates to novel and non-obvious methods of treating patients by administering the compositions of the invention. In one embodiment, the Cordyceps sinensis mycelia is Paecilomyces hepiali mycelia. In another embodiment the compositions of the invention are used to treat patients infected with hepatitis C.Type: ApplicationFiled: August 6, 2009Publication date: January 28, 2010Inventors: Ya-Chun Wang, Wang-Sheng Ko, Chih-Cheng Chang
-
Publication number: 20100021556Abstract: A method for producing an agent against an infectious disease, particularly HIV, Ebola, or similar. In the method, a pressurized, especially medical oxygen is swirled into a solution containing at least one plant component particularly in the form of an extract.Type: ApplicationFiled: October 31, 2007Publication date: January 28, 2010Inventor: Rupert Temper
-
Publication number: 20100015109Abstract: A dietary supplement composition having an ORAC value in excess of at least about 2,500 and which can be readily consumed in a small quantity is provided for supplementing an individual's daily intake. The dietary supplement composition suitably includes organic and/or vegan ingredients and can be consumed in quantities of as little as about 1 tablespoon to provide an amount of antioxidants equivalent to at least the minimum recommended daily intake of five to nine servings of fruits and/or vegetables.Type: ApplicationFiled: July 15, 2009Publication date: January 21, 2010Inventor: Scott Bias
-
Publication number: 20090324635Abstract: Provided is caspofungin free of caspofungin impurity A, methods for preparation thereof and isolation of caspofungin impurity A.Type: ApplicationFiled: June 25, 2009Publication date: December 31, 2009Inventors: Ferenc Korodi, Piroska Kovacs, Chaim Eidelman, Avi Tovi, Hagi Alon
-
Patent number: 7635492Abstract: An aqueous formulation comprising edible fungal particles especially consisting substantially of fungal mycelia is described. The ingredient maybe combined with other ingredients to produce a wide range of foodstuffs or food ingredients including desserts (e.g. yogurt), reconstitutable drinks or soup and extruded foodstuffs (e.g. savory snack foods). Foodstuffs prepared may have medical applications (e.g. for treatment of joint mobility disorders, reducing fat uptake, lowering cholesterol, immune function stimulation, use on a pre-biotic and/or for affecting satiety).Type: GrantFiled: April 7, 2002Date of Patent: December 22, 2009Assignee: Marlow Foods LimitedInventors: Timothy John Andrew Finnigan, Robin Blanchard
-
Publication number: 20090291100Abstract: A therapeutic agent for treating polycystic ovary syndrome (PCOS), which exhibits few, if any, side effects, is effective at inducing ovulation, and is safely available for not only females who desire to bear children, but also for unmarried or young females. A therapeutic agent for polycystic ovary syndrome (PCOS) in which an extract of mushrooms is contained as the active ingredient thereof is used.Type: ApplicationFiled: August 4, 2009Publication date: November 26, 2009Inventors: Kunihiko Tominaga, Hideo Anzai, Cun Zhuang
-
Publication number: 20090285789Abstract: The present invention is related to a method for enhancing innate and adaptive immunity by activating dendritic cells (DCs) and macrophages, comprising administering a subject LZ-8 protein. The present invention is also related to a composition for enhancing innate and adaptive immunity, comprising LZ-8 protein.Type: ApplicationFiled: May 15, 2009Publication date: November 19, 2009Applicant: YEASTERN BIOTECH CO., LTDInventors: Ching-Liang Chu, Tzu-Chih Chen
-
Patent number: 7618638Abstract: The object of the present invention is to provide a preventive and relieving medicine for activated matrix metalloproteinase-causing disorders and diseases, which contains a solvent extract of Ganoderma mushroom. The preventive and relieving medicine for activated matrix metalloproteinase (MMP)-causing disorders and diseases according to the present invention contains the solvent extract of Ganoderma mushroom. The solvent extract of Ganoderma mushroom has MMP inhibiting behaviors and is effective for prevention, suppression, and symptomatic relief of various activated MMP-causing disorders and diseases, such as metastasis of cancers, ulceration, rheumatoid arthritis, osteoporosis, periodontitis, and aging of skin.Type: GrantFiled: September 27, 2002Date of Patent: November 17, 2009Assignee: Nippon Menard Cosmetic Co., Ltd.Inventors: Koji Hattori, Hiroshi Mizutani, Kazuhisa Osumi
-
Publication number: 20090274721Abstract: Disclosed are topical compositions comprising extracts of Hypsizygus ulmarius in amounts that are effective to influence LTB4-mediated chemotaxis and/or IL-1? mediated adhesion of polymorphonuclear leukocytes. The Hypsizygus ulmarius extract may be used alone or in combination with secondary anti-inflammatory and skin active agents, such as other mushroom and/or natural extracts. The secondary anti-inflammatory agents may or may not function by antagonizing LTB4-mediated chemotaxis and IL-1? mediated adhesion. The extract may be incorporated into a cosmetically acceptable vehicle. The present invention includes methods of treating skin inflammation by applying to inflamed skin, anti-inflammatory effective amounts of Hypsizygus ulmarius extract in a defined treatment regimen.Type: ApplicationFiled: July 7, 2009Publication date: November 5, 2009Inventors: Chia Chen, Andrew Weil, Paul Stamets
-
Publication number: 20090274722Abstract: The invention relates to a therapeutic composition for the prevention and/or treatment of Benign Prostatic Hyperplasia (BPH) and other related prostate problems. The invention is a therapeutic composition that combines alfalfa and fennel to have a synergistic effect for the treatment of prostate problems, erectile dysfunction, and/or sleep disorders. The composition may further include ginger, red Reishi mushroom and oyster mushroom.Type: ApplicationFiled: July 15, 2009Publication date: November 5, 2009Inventor: John E. Ligums
-
Publication number: 20090274720Abstract: A fat-soluble fraction extracted from the fruiting body of Hericium erinaceum is demonstrated to inhibit the neuronal toxicity of amyloid beta-peptide (A?) and induce the synthesis of nerve growth factor (NGF), and has great potential as an active ingredient for pharmaceutical products, health food products, food products and/or beverages to prevent and/or treat dementia, especially Alzheimer-type dementia. This invention is to provide the bioactive fraction and its preparation method.Type: ApplicationFiled: May 2, 2008Publication date: November 5, 2009Inventors: Cun Zhuang, Hirokazu Kawagishi, Luyong Zhang, Hideo Anzai
-
Patent number: 7611715Abstract: A foodstuff capable of preventing the induction or metastasis of cancer is provided. In particular, an Agaricus blazei Murill extract comprising an ingredient capable of preventing the induction or metastasis of cancer is provided. The ingredient can be a chromatographic main elute fraction of 100 to 2000 molecular weight, obtained by the steps of extracting the fruit body of Agaricus blazei Murill with hot water, dialyzing the resultant extract, and subjecting the thus obtained dialysis external fluid to chromatography. Alternatively, the ingredient can be a dialysis external fluid obtained by the steps of extracting the fruit body of Agaricus blazeiMurill with hot water, adding ethanol to the resultant extract to thereby obtain precipitates, dissolving the precipitates in water, and dialyzing the solution.Type: GrantFiled: April 19, 2007Date of Patent: November 3, 2009Assignee: SSI Co., Ltd.Inventors: Insu Peter Lee, Tomihisa Ota
-
Patent number: 7608270Abstract: A pharmaceutical or dietetic dosage form comprising of effective quantity of an active substance chemically or physically bound to a support comprising sporopollenin, or other similar exine coating of spores, of a plant or fungus, optionally with further excipients.Type: GrantFiled: June 25, 2004Date of Patent: October 27, 2009Assignee: University of HullInventors: Stephen Thomas Beckett, Stephen Lawrence Atkin, Grahame Mackenzie
-
Publication number: 20090263415Abstract: An object of the present invention is to provide scalp and hair of scalp composition which realizes hair growing, hair growth or the like by arranging the scalp environment without inhibiting the function of sebaceous membrane and dark cell (superficial type cell) of scalp. To achieve the object, the present invention provides a composition which contains extraction component of fungi belonging to basidiomycetes and extraction component of the root of a plant of Araliceae. The composition may contain fats and fatty oils of Hippophae rhamnoides L. whose raw material is fruit and/or seed of Elaeagnaceae Hippophae rhamnoides L. plant.Type: ApplicationFiled: May 21, 2009Publication date: October 22, 2009Inventors: Tadashi GOINO, Noriko Umetsu, Tsuzuki Kitamura
-
Publication number: 20090257984Abstract: The present invention relates to compositions containing the fungus Alternaria alternata and/or the secondary metabolites thereof, which belong to the family of the diketopiperazines (DKPs), for controlling the pathogen fungus Plasmopara viticola.Type: ApplicationFiled: June 14, 2007Publication date: October 15, 2009Inventors: Rita Musetti, Stefano Borselli, Michele D'Ambrosio
-
Publication number: 20090252757Abstract: This invention provides novel HIV-interacting host factors. The invention also provides methods of using the HIV-interacting host factors to screen for compounds that inhibit HIV infection. The methods comprise first screening test compounds for modulators of an HIV interacting host factor disclosed herein, and then further screening the identified modulating compounds for ability to inhibit HIV infection. The invention further provides methods and pharmaceutical compositions for treating diseases and conditions associated with HIV infection.Type: ApplicationFiled: December 8, 2006Publication date: October 8, 2009Applicant: IRM LLCInventors: Deborah Nguyen, Kelli L. Kuhen, Jeremy S. Caldwell
-
Patent number: 7597910Abstract: Compositions and methods are described for the treatment of prostatitis, benign prostatic hypertrophy, and prostate cancer. The compositions contain either aqueous extracts or dried mixtures of selenium- and zinc-enriched cannabis plant material, shiitake mushrooms, and maitake mushrooms. The compositions are effective in treating prostate disorders by alleviating pain and voiding symptoms, decreasing inflammation and prostate size, reducing cellular proliferation in prostate tissue, and/or reducing PSA levels to within the normal range of 0-4.Type: GrantFiled: August 20, 2005Date of Patent: October 6, 2009Assignee: SLGM Medical Research InstituteInventor: John W. McDowell, Jr.
-
Publication number: 20090246152Abstract: The invention relates to agents for sequestering serum aging factors, and methods for using the same. More particularly, the invention relates to agents termed herein “Naractin” to denote any one of several naturally-occurring arNOX inhibitors either present in N. tazetta powder or capable of augmenting N. tazetta powder to an inhibitory level comparable to that of the fresh N. tazetta extracts, and to methods for using “Naractins” to prevent or treat disorders and complications of disorders resulting from cell damage caused by an aging-related isoform of NADH oxidase (arNOX). In one exemplary embodiment the agents of the invention comprise at least one naturally occurring Naractin. Such naturally occurring naractins are also capable of augmenting the anti-arNOX effect of other naturally occurring arNOX inhibitory agents.Type: ApplicationFiled: March 28, 2008Publication date: October 1, 2009Applicant: Nu Skin International, Inc.Inventors: Dale Kern, Christiaan Meadows
-
Patent number: 7595055Abstract: The present invention relates to a non-polar solvent soluble extract, polyphenol fractions therefrom and the compounds isolated from Elfvingia applanata, which shows a therapeutic activity for diabetes and diabetic complications, and a pharmaceutical composition for the treatment of diabetes and diabetic complications comprising the same.Type: GrantFiled: March 3, 2003Date of Patent: September 29, 2009Inventors: Dal-Hoon Son, Sung-Soon Son
-
Publication number: 20090226481Abstract: A composition having an activity of ameliorating the reduced amount of diurnal activity and/or depressive symptoms, comprising arachidonic acid and/or a compound having arachidonic acid as a constituent fatty acid.Type: ApplicationFiled: June 29, 2006Publication date: September 10, 2009Inventors: Yoshiyuki Ishikura, Yoshihiko Koga
-
Publication number: 20090226482Abstract: An herbal composition comprises an extract of Radix Rehmanniae, and an extract of Poria, Ganoderma Lucidum, Semen Ziziphi Spinosae, Semen Platycladi, Radix Rehmanniae Praeparata, Radix Angelicae Sinensis, Radix Et Rhizoma Salviae Miltiorrhizae, Rhizoma Chuanxiong, Rhizoma Atractylodis Macrocephalae, Fructus Gardeniae, Cortex Moutan, Radix Bupleuri, Radix Paeoniae Alba, Rhizoma Cyperi, Pericarpium Citri Reticulatae, Fructus Aurantii, Radix Glycyrrhizae, and Os Draconis. The herbal composition is prepared by separately extracting Radix Rehmanniae, and the remaining herbs. The composition is suitable for treatment of insomnia and other related disorders.Type: ApplicationFiled: March 4, 2008Publication date: September 10, 2009Inventor: Hei Ling Helen CHAN
-
Publication number: 20090208525Abstract: The present invention provides an antioxidant and a whitening agent having high safety, and a external preparation for skin using the same. The antioxidant and whitening agent comprise, as an effective component, one or more extracts from Basidiomycetes selected from the group consisting of Pleurotus abalonus, Pholiota squarrosa, Onnia orientalis, Astraeus hygrometricus and Pleurotus nebrodensis. These extracts have a free radical capturing ability and are useful for suppressing skin oxidation and for preventing and improving skin aging. In addition, the extracts have a tyrosinase activity inhibiting action and can suppress the melanin generation. Since the fruit bodies of these Basidiomycetes have been used for edible purpose and have high safety, they can be used preferably for an external preparation for skin.Type: ApplicationFiled: February 9, 2009Publication date: August 20, 2009Applicants: SHISEIDO CO., LTD.Inventors: Takeshi Nawamura, Nobuhiko Ochiai, Masato Hatao, Mineyuki Yokoyama, Koji Kobayashi, Fumio Eguchi
-
Publication number: 20090196885Abstract: This invention relates to a method of treating cancer by administering to a subject in need thereof an effective amount of a mevalonate pathway inhibitor and an effective amount of an Antrodia camphorata extract.Type: ApplicationFiled: April 9, 2009Publication date: August 6, 2009Applicant: National Health Research InstitutesInventors: Chih-Jung Yao, Shuang-En Chuang, Gi-Ming Lai, Chin-Feng Chan
-
Publication number: 20090181047Abstract: Methods and compositions for reducing and/or inhibiting inflammation by topical application of dermatocosmetic compositions comprising effective amounts of extracts of Coriolus versicolor that have been hydrolyzed by an acid protease, preferably Rhizomucor miehei, and thereafter rendered substantially devoid of acid-protease activity.Type: ApplicationFiled: January 14, 2008Publication date: July 16, 2009Inventors: Michael Bishop, Elysiann Bishop, Walter Smith, Glen Gillis